abstract |
The present invention relates to 3-chromocarboxylic acid derivatives, pharmaceutically acceptable salts thereof, which are useful for the treatment of obesity and lipid abnormalities as well as non-insulin dependent diabetes mellitus (type II diabetes) and the associated vascular disease. It's about prodrugs. |